… CLAD is a progressive and irreversible … A follow up study of patients with BOS demonstrated
stabilization of lung function almost a year after starting MMF [35]. A retrospective study …

… sufficiently large group of patients with adequate follow-up, it will almost certainly stimulate
… disease with extracorporeal photochemotherapy: progressive systemic sclerosis, Yale J. Biol…

… Extracorporeal photochemotherapy (ECP), in combination with other immunosuppressive
agents, is a very useful option [18]. With ECP, at an extracorporeal … After 2 years of follow-up, …

… therapy frequently undergo extracorporeal photopheresis (ECP) … to rise over time and studies
with follow‐up up to 20 years … Successful use of extracorporeal photochemotherapy in the …

… , extracorporeal photochemotherapy, or extracorporeal … where ECP is used include
systemic sclerosis, graft-versus-… Follow-up work showed that ruxolitinib was broadly active in …

… It can also be used as a follow-up tool but its usefulness in everyday practice is limited. … In
a 10-year follow-up study of oral precancer, Gupta et al, in 1980, calculated the incidence rate …

… , and extracorporeal photopheresis provides an excellent adjuvant strategy. Ongoing studies
… Follow-up trials for acute GVHD involve the use of ST2, REG3alpha (regenerating islet-…

… cirrhosis, pulmonary fibrosis, systemic sclerosis, and GVHD, … While the driver antigen remains
to be elucidated, this study … Due to multifactorial aspects of this disease, careful follow up …

… Penicillins show some positive effects in localized and systemic scleroderma. Penicillins
with extended spectrum are ampicillin, amoxicillin, ticarcillin, piperacillin, and mezlocillin. They …

… This remains challenging as studies need a minimum of 1 year of follow-up to assess relevant
endpoints of cGvHD (12). In this regard, an important consideration for paediatric studies …